Design Therapeutics, Inc.

Rachunek Zysków i Strat





Przychody TTM (mln): 1
EBIT TTM (mln): -61
index 0 1 2 3 4 5
Rok finansowy 2019 2020 2021 2022 2023 2024
Przychód (mln) 0 0 0 0 0 0
Przychód Δ r/r 0.0% -72.9% -100.0% 0.0% 0.0% 0.0%
Marża brutto -98.3% -2112.4% -inf% -inf% 0.0% 0.0%
EBIT (mln) -2 -8 -36 -68 -78 -62
EBIT Δ r/r 0.0% 336.6% 330.1% 88.6% 15.7% -20.2%
EBIT (%) -228777.0% -3685840.7% 0.0% 0.0% 0.0% 0.0%
Koszty finansowe (mln) 0 0 0 -5 0 0
EBITDA (mln) -2 -8 -36 -68 -78 -62
EBITDA(%) -228777.0% -3683628.3% 0.0% 0.0% 0.0% 0.0%
Podatek (mln) -0 0 0 -5 0 0
Zysk Netto (mln) -2 -8 -36 -59 -67 -50
Zysk netto Δ r/r 0.0% 304.5% 329.1% 65.0% 14.1% -25.8%
Zysk netto (%) -245443.6% -3663716.8% 0.0% 0.0% 0.0% 0.0%
EPS -0.0753 -0.15 -0.77 -1.05 -0.0012 -0.88
EPS (rozwodnione) -0.0753 -0.15 -0.77 -1.05 -0.0012 -0.88
Ilośc akcji (mln) 27 54 46 56 55,985 57
Ważona ilośc akcji (mln) 27 54 46 56 55,985 57
Waluta USD USD USD USD USD USD